Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PGF |
| Upstream (Parents) |
|---|
| (<<) AKT3 → PGF |
| (<<) CHST3 → PGF |
| (<<) CRYAB → PGF |
| (<<) EFEMP1 → PGF |
| (<<) ISLR → PGF |
| (<<) LARP6 → PGF |
| (<<) MAP2K1 → PGF |
| (<<) MYL9 → PGF |
| (<<) RASSF1 → PGF |
| (<<) SEPW1 → PGF |
| (<<) STK17A → PGF |
| (<<) TIMP1 → PGF |
| Downstream (Children) |
|---|
| PGF → BBC3 (>>) |
| PGF → CDK6 (>>) |
| PGF → CEND1 (>>) |
| PGF → CHST2 (>>) |
| PGF → DDIT3 (>>) |
| PGF → DRD4 (>>) |
| PGF → HEY1 (>>) |
| PGF → KLK3 (>>) |
| PGF → MAP3K6 (>>) |
| PGF → NAV2 (>>) |
| PGF → NPC1 (>>) |
| PGF → POLR1B (>>) |
| PGF → PRKACA (>>) |
| PGF → SOD3 (>>) |
| PGF → STAT5B (>>) |
